JP2002540204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540204A5 JP2002540204A5 JP2000608007A JP2000608007A JP2002540204A5 JP 2002540204 A5 JP2002540204 A5 JP 2002540204A5 JP 2000608007 A JP2000608007 A JP 2000608007A JP 2000608007 A JP2000608007 A JP 2000608007A JP 2002540204 A5 JP2002540204 A5 JP 2002540204A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidinyl
- ethyl
- dichlorophenoxy
- amino
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 cyano, hydroxyl Chemical group 0.000 description 65
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 48
- 150000001875 compounds Chemical class 0.000 description 22
- 125000000217 alkyl group Chemical group 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 239000012453 solvate Substances 0.000 description 8
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 6
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 125000002947 alkylene group Chemical group 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 description 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 2
- MHIFSXJQGYPPDB-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MHIFSXJQGYPPDB-UHFFFAOYSA-N 0.000 description 2
- FTAFETTVRQXSRZ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 FTAFETTVRQXSRZ-UHFFFAOYSA-N 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N Sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- BPPZIPHINXIUFJ-UHFFFAOYSA-N [1-[2-[(5-chloro-1,3-dimethylpyrazol-4-yl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound CC1=NN(C)C(Cl)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 BPPZIPHINXIUFJ-UHFFFAOYSA-N 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000004432 carbon atoms Chemical group C* 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005842 heteroatoms Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 200000000018 inflammatory disease Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atoms Chemical group O* 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000005030 pyridylthio group Chemical group N1=C(C=CC=C1)S* 0.000 description 2
- 229960001663 sulfanilamide Drugs 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- CCEKWQBFPXXKBN-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(2-methylpropylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCC(C)C)CCC1C(=O)C1=CC=C(Cl)C=C1 CCEKWQBFPXXKBN-UHFFFAOYSA-N 0.000 description 1
- QWDIDFWRSBMBFV-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(3-methylsulfanylbutylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCCC(C)SC)CCC1C(=O)C1=CC=C(Cl)C=C1 QWDIDFWRSBMBFV-UHFFFAOYSA-N 0.000 description 1
- CBFALSMXAFBKBY-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(pyridin-2-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N=CC=CC=2)CC1 CBFALSMXAFBKBY-UHFFFAOYSA-N 0.000 description 1
- HIRXHSWOYNEDIE-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(pyridin-4-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=CN=CC=2)CC1 HIRXHSWOYNEDIE-UHFFFAOYSA-N 0.000 description 1
- DPZYXLJALIJPHJ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-(quinolin-3-ylmethylamino)ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=C3C=CC=CC3=NC=2)CC1 DPZYXLJALIJPHJ-UHFFFAOYSA-N 0.000 description 1
- CAMLOMWWSRNMDR-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(1-methylbenzimidazol-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound N=1C2=CC=CC=C2N(C)C=1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 CAMLOMWWSRNMDR-UHFFFAOYSA-N 0.000 description 1
- RMTAXKXHFKSHPJ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,4-dimethoxypyrimidin-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound COC1=NC(OC)=NC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 RMTAXKXHFKSHPJ-UHFFFAOYSA-N 0.000 description 1
- BZZQZDAWAXXDRW-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,5-difluorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound FC1=CC=C(F)C(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BZZQZDAWAXXDRW-UHFFFAOYSA-N 0.000 description 1
- QNHDEZAQQYUODX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,6-dichlorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=CC=CC=2Cl)Cl)CC1 QNHDEZAQQYUODX-UHFFFAOYSA-N 0.000 description 1
- PLIWJSGXSUYJCZ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2,6-dichloropyridin-4-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C=C(Cl)N=C(Cl)C=2)CC1 PLIWJSGXSUYJCZ-UHFFFAOYSA-N 0.000 description 1
- FIHOVKRJUWICRZ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-chloroquinolin-3-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=NC3=CC=CC=C3C=2)Cl)CC1 FIHOVKRJUWICRZ-UHFFFAOYSA-N 0.000 description 1
- CCKAMSOSAWJYBF-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-fluoro-4,5-dimethoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C(OC)C(OC)=CC(F)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 CCKAMSOSAWJYBF-UHFFFAOYSA-N 0.000 description 1
- FBZOJNNRWXMQGT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-phenyl-1H-imidazol-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N=C(NC=2)C=2C=CC=CC=2)CC1 FBZOJNNRWXMQGT-UHFFFAOYSA-N 0.000 description 1
- CRHYLKKTXOMRKU-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(2-phenylpyrazol-3-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2N(N=CC=2)C=2C=CC=CC=2)CC1 CRHYLKKTXOMRKU-UHFFFAOYSA-N 0.000 description 1
- NIRSYNGGTPBPRP-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3,4,5-trimethoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound COC1=C(OC)C(OC)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 NIRSYNGGTPBPRP-UHFFFAOYSA-N 0.000 description 1
- BQSJOJBQVLBVLW-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3,5-difluorophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound FC1=CC(F)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BQSJOJBQVLBVLW-UHFFFAOYSA-N 0.000 description 1
- GQWDJTMFSZHGMX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-hydroxy-4-methoxyphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C(O)C(OC)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 GQWDJTMFSZHGMX-UHFFFAOYSA-N 0.000 description 1
- NTICZMKTSNVWMT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-hydroxy-4-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=C([N+]([O-])=O)C(O)=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 NTICZMKTSNVWMT-UHFFFAOYSA-N 0.000 description 1
- LRKHJDIAAFTZID-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-methylthiophen-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CSC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1C LRKHJDIAAFTZID-UHFFFAOYSA-N 0.000 description 1
- IRHNODZMYZXIQC-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-nitro-4-pyridin-2-ylsulfanylphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C=1C=C(SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 IRHNODZMYZXIQC-UHFFFAOYSA-N 0.000 description 1
- ZGEADYISVFOZKM-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(3-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 ZGEADYISVFOZKM-UHFFFAOYSA-N 0.000 description 1
- SNSLWGMYHQXIKB-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(4-nitrophenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SNSLWGMYHQXIKB-UHFFFAOYSA-N 0.000 description 1
- LALDGZAOEXVHEY-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(4-phenylpiperidin-4-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC2(CCNCC2)C=2C=CC=CC=2)CC1 LALDGZAOEXVHEY-UHFFFAOYSA-N 0.000 description 1
- QQZVTJZQPKPZAV-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(5-ethylthiophen-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound S1C(CC)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 QQZVTJZQPKPZAV-UHFFFAOYSA-N 0.000 description 1
- OVNYNSHJGJUENX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(5-nitro-2-pyridin-2-ylsulfanylphenyl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound C1CC(C(=O)C=2C=CC(Cl)=CC=2)CCN1CCNCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC=N1 OVNYNSHJGJUENX-UHFFFAOYSA-N 0.000 description 1
- PSTVENQTOPIJHX-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(6-methylpyridin-2-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound CC1=CC=CC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=N1 PSTVENQTOPIJHX-UHFFFAOYSA-N 0.000 description 1
- LQNLIYRHRPZSPL-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(6-nitro-1,3-benzodioxol-5-yl)methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=2OCOC=2C=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 LQNLIYRHRPZSPL-UHFFFAOYSA-N 0.000 description 1
- PFYFSSBSMWQHOT-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[(7-hydroxy-3,7-dimethyloctyl)amino]ethyl]piperidin-4-yl]methanone Chemical compound C1CN(CCNCCC(CCCC(C)(C)O)C)CCC1C(=O)C1=CC=C(Cl)C=C1 PFYFSSBSMWQHOT-UHFFFAOYSA-N 0.000 description 1
- USCYTAXQSSZRJK-OWOJBTEDSA-N (4-chlorophenyl)-[1-[2-[[(E)-3-(4-nitrophenyl)prop-2-enyl]amino]ethyl]piperidin-4-yl]methanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 USCYTAXQSSZRJK-OWOJBTEDSA-N 0.000 description 1
- NTMOXDJIDPKQKQ-UHFFFAOYSA-N (4-chlorophenyl)-[1-[2-[[5-(3-nitrophenyl)furan-2-yl]methylamino]ethyl]piperidin-4-yl]methanone Chemical compound [O-][N+](=O)C1=CC=CC(C=2OC(CNCCN3CCC(CC3)C(=O)C=3C=CC(Cl)=CC=3)=CC=2)=C1 NTMOXDJIDPKQKQ-UHFFFAOYSA-N 0.000 description 1
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 description 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- ZWXDDWDWMCESKH-RMKNXTFCSA-N (E)-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-phenylprop-2-enamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)\C=C\C=2C=CC=CC=2)CC1 ZWXDDWDWMCESKH-RMKNXTFCSA-N 0.000 description 1
- GNTLPZAHICFRRC-XCVCLJGOSA-N (E)-N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-(4-nitrophenyl)prop-2-enamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 GNTLPZAHICFRRC-XCVCLJGOSA-N 0.000 description 1
- ZOPXEBJEWRETPJ-IZZDOVSWSA-N (E)-N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-phenylprop-2-enamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)\C=C\C=2C=CC=CC=2)CC1 ZOPXEBJEWRETPJ-IZZDOVSWSA-N 0.000 description 1
- BMHUXUQPWBADAL-UHFFFAOYSA-N 2-[2-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-4-nitrophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C([N+]([O-])=O)C=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 BMHUXUQPWBADAL-UHFFFAOYSA-N 0.000 description 1
- GUXFOLSWRZODOX-UHFFFAOYSA-N 2-[3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2,4-dioxoquinazolin-1-yl]-N,N-dimethylacetamide;hydrochloride Chemical compound Cl.O=C1N(CC(=O)N(C)C)C2=CC=CC=C2C(=O)N1CCN(CC1)CCC1C(=O)C1=CC=C(F)C=C1 GUXFOLSWRZODOX-UHFFFAOYSA-N 0.000 description 1
- NSFBBZNOSVHEES-UHFFFAOYSA-N 2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-N-[(3-methoxyphenyl)methyl]ethanamine;dihydrochloride Chemical compound Cl.Cl.COC1=CC=CC(CNCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 NSFBBZNOSVHEES-UHFFFAOYSA-N 0.000 description 1
- XNGVLISOMZWKAQ-UHFFFAOYSA-N 2-[[2-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 XNGVLISOMZWKAQ-UHFFFAOYSA-N 0.000 description 1
- OLFUWQFGAVROEA-UHFFFAOYSA-N 2-[[2-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-4-yl]amino]ethanol Chemical compound OCCNC1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 OLFUWQFGAVROEA-UHFFFAOYSA-N 0.000 description 1
- PVPXVESRTMPRRZ-UHFFFAOYSA-N 2-[[4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]pyrimidin-2-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 PVPXVESRTMPRRZ-UHFFFAOYSA-N 0.000 description 1
- ZNLBTLXZEMUXOG-UHFFFAOYSA-N 2-[[4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]pyrimidin-2-yl]amino]ethanol Chemical compound OCCNC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ZNLBTLXZEMUXOG-UHFFFAOYSA-N 0.000 description 1
- SSDVFNNGIZCJGU-UHFFFAOYSA-N 2-[[4-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-2-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 SSDVFNNGIZCJGU-UHFFFAOYSA-N 0.000 description 1
- VVWOJGLYFQOSHE-UHFFFAOYSA-N 2-[[4-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]pyrimidin-2-yl]amino]ethanol Chemical compound OCCNC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 VVWOJGLYFQOSHE-UHFFFAOYSA-N 0.000 description 1
- QPIPEHZSHGDUEL-UHFFFAOYSA-N 2-acetamido-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-thiazole-4-carboxamide Chemical compound S1C(NC(=O)C)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 QPIPEHZSHGDUEL-UHFFFAOYSA-N 0.000 description 1
- PFODAJFKGNHIKF-UHFFFAOYSA-N 2-amino-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-thiazole-4-carboxamide Chemical compound S1C(N)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 PFODAJFKGNHIKF-UHFFFAOYSA-N 0.000 description 1
- WFTYOJFJHQSUGC-UHFFFAOYSA-N 2-bromo-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxybenzamide Chemical compound COC1=CC=C(Br)C(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 WFTYOJFJHQSUGC-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- ZJWLHFWEFOMZAL-UHFFFAOYSA-N 3-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-6-methoxy-1H-quinazoline-2,4-dione Chemical compound O=C1C2=CC(OC)=CC=C2NC(=O)N1CCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 ZJWLHFWEFOMZAL-UHFFFAOYSA-N 0.000 description 1
- QWSWUJUPZKKMCB-UHFFFAOYSA-N 3-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-6,7-dimethylchromen-4-one Chemical compound O=C1C=2C=C(C)C(C)=CC=2OC=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 QWSWUJUPZKKMCB-UHFFFAOYSA-N 0.000 description 1
- KFFDPUVRJFFJRV-UHFFFAOYSA-N 3-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]chromen-4-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(C3=CC=CC=C3OC=2)=O)CC1 KFFDPUVRJFFJRV-UHFFFAOYSA-N 0.000 description 1
- JXLSUJLHSUIKHP-UHFFFAOYSA-N 3-amino-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 JXLSUJLHSUIKHP-UHFFFAOYSA-N 0.000 description 1
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 1
- UXWWZPILDBNLQO-UHFFFAOYSA-N 3-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]benzamide;hydrochloride Chemical compound Cl.ClC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 UXWWZPILDBNLQO-UHFFFAOYSA-N 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- APSKKFUPDZBWNV-UHFFFAOYSA-N 4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1CNCCN(CC1)CCC1C(=O)C1=CC=C(Cl)C=C1 APSKKFUPDZBWNV-UHFFFAOYSA-N 0.000 description 1
- SOURVZNLNIJWDC-UHFFFAOYSA-N 4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-4-ethylhexanenitrile Chemical compound C1CN(CCNCC(CC)(CCC#N)CC)CCC1C(=O)C1=CC=C(Cl)C=C1 SOURVZNLNIJWDC-UHFFFAOYSA-N 0.000 description 1
- BAXBAKNPTIKXDR-UHFFFAOYSA-N 4-amino-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 BAXBAKNPTIKXDR-UHFFFAOYSA-N 0.000 description 1
- MSLRDSZTCIDZOZ-UHFFFAOYSA-N 4-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-[2-(dimethylamino)-2-oxoethoxy]benzamide Chemical compound CN(C)C(=O)COC1=CC(Cl)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MSLRDSZTCIDZOZ-UHFFFAOYSA-N 0.000 description 1
- LXRQUFJGFDAHOE-UHFFFAOYSA-N 4-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound C1=C(Cl)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 LXRQUFJGFDAHOE-UHFFFAOYSA-N 0.000 description 1
- JHZCXLDNXHWXJA-UHFFFAOYSA-N 4-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-nitrobenzamide Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 JHZCXLDNXHWXJA-UHFFFAOYSA-N 0.000 description 1
- UDLQORCFOQLNRB-UHFFFAOYSA-N 5-bromo-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC(Br)=CC=2)CC1 UDLQORCFOQLNRB-UHFFFAOYSA-N 0.000 description 1
- NPMFBHDRRWILOH-UHFFFAOYSA-N 5-chloro-N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound N1=CC(Cl)=CC=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 NPMFBHDRRWILOH-UHFFFAOYSA-N 0.000 description 1
- MNMGURNXXQQXDV-UHFFFAOYSA-N 6-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]-1,3-dimethylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 MNMGURNXXQQXDV-UHFFFAOYSA-N 0.000 description 1
- MMXKXXGRZUAQGP-UHFFFAOYSA-N 6-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione Chemical compound O=C1N(C)C(=O)N(C)C(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 MMXKXXGRZUAQGP-UHFFFAOYSA-N 0.000 description 1
- AWFDLYTZOASVKX-UHFFFAOYSA-N 6-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]-2-methylsulfanylpyridine-3-carbonitrile Chemical compound C1=C(C#N)C(SC)=NC(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 AWFDLYTZOASVKX-UHFFFAOYSA-N 0.000 description 1
- ATAPQCXFQQJJQF-UHFFFAOYSA-N 6-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyrazin-2-amine Chemical compound ClC1=CN=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ATAPQCXFQQJJQF-UHFFFAOYSA-N 0.000 description 1
- GDPQAWMLYMBYKE-UHFFFAOYSA-N 6-chloro-N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyridazin-3-amine Chemical compound N1=NC(Cl)=CC=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 GDPQAWMLYMBYKE-UHFFFAOYSA-N 0.000 description 1
- WWRGONNHZFUSAT-UHFFFAOYSA-N 6-chloro-N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyrazin-2-amine Chemical compound ClC1=CN=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 WWRGONNHZFUSAT-UHFFFAOYSA-N 0.000 description 1
- DYXDOWBDPGAJHK-UHFFFAOYSA-N 6-chloro-N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridazin-3-amine Chemical compound N1=NC(Cl)=CC=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DYXDOWBDPGAJHK-UHFFFAOYSA-N 0.000 description 1
- OVGRJQQHTOESDL-UHFFFAOYSA-N 6-chloro-N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound ClC1=CC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 OVGRJQQHTOESDL-UHFFFAOYSA-N 0.000 description 1
- 102100007451 ANAPC1 Human genes 0.000 description 1
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 description 1
- HKNFOAKZDXBKRA-UHFFFAOYSA-N CC1(NC(=CC(=N1)N)C)N Chemical compound CC1(NC(=CC(=N1)N)C)N HKNFOAKZDXBKRA-UHFFFAOYSA-N 0.000 description 1
- BLRWPDDIYQWCLQ-UHFFFAOYSA-N N-[1-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-3-methylbutan-2-yl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC(CN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)C(C)C)=C1 BLRWPDDIYQWCLQ-UHFFFAOYSA-N 0.000 description 1
- GKLCGRWCVOIQRH-UHFFFAOYSA-N N-[1-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-3-methylbutan-2-yl]-4-methylbenzamide Chemical compound C=1C=C(C)C=CC=1C(=O)NC(C(C)C)CN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 GKLCGRWCVOIQRH-UHFFFAOYSA-N 0.000 description 1
- KETMPDYDKCWDQW-UHFFFAOYSA-N N-[2-[4-(3,4-dichloroanilino)piperidin-1-yl]ethyl]-3-methoxybenzamide;dihydrochloride Chemical compound Cl.Cl.COC1=CC=CC(C(=O)NCCN2CCC(CC2)NC=2C=C(Cl)C(Cl)=CC=2)=C1 KETMPDYDKCWDQW-UHFFFAOYSA-N 0.000 description 1
- NVFNOMAXNHPMEV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorobenzoyl)piperazin-1-yl]ethyl]-3-methoxybenzamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C(=O)NCCN2CCN(CC2)C(=O)C=2C=C(Cl)C(Cl)=CC=2)=C1 NVFNOMAXNHPMEV-UHFFFAOYSA-N 0.000 description 1
- QIIHHUHGQJPRND-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzodioxole-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=C3OCOC3=CC=2)CC1 QIIHHUHGQJPRND-UHFFFAOYSA-N 0.000 description 1
- KWXJUNDUJSJTBH-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2SC3=CC=CC=C3N=2)CC1 KWXJUNDUJSJTBH-UHFFFAOYSA-N 0.000 description 1
- QLDSETCYASKHSM-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,3-benzoxazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2OC3=CC=CC=C3N=2)CC1 QLDSETCYASKHSM-UHFFFAOYSA-N 0.000 description 1
- KQSSUXAOULQXIV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1,8-naphthyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C3N=CC=CC3=CC=2)CC1 KQSSUXAOULQXIV-UHFFFAOYSA-N 0.000 description 1
- SJDLHXHEAZDEPB-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1-methylpyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CN=C2N(C)N=CC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 SJDLHXHEAZDEPB-UHFFFAOYSA-N 0.000 description 1
- ZISSECHEDKXQAI-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-1H-imidazole-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=CNC=2)CC1 ZISSECHEDKXQAI-UHFFFAOYSA-N 0.000 description 1
- LGAZSGRGURZRHR-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,4-difluorobenzamide Chemical compound FC1=CC(F)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 LGAZSGRGURZRHR-UHFFFAOYSA-N 0.000 description 1
- PCKWFEMVMVVWBW-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,4-dimethyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NC(C)=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 PCKWFEMVMVVWBW-UHFFFAOYSA-N 0.000 description 1
- VNNOZQFEDPIYTO-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,5-dimethyl-1,3-oxazole-4-carboxamide Chemical compound O1C(C)=NC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1C VNNOZQFEDPIYTO-UHFFFAOYSA-N 0.000 description 1
- ISWAUFMGBSNAHJ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2,6-dimethoxypyrimidin-4-amine Chemical compound COC1=NC(OC)=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ISWAUFMGBSNAHJ-UHFFFAOYSA-N 0.000 description 1
- LHCHQRNVSKTWFV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-(methylsulfanylmethyl)pyrimidin-4-amine Chemical compound CSCC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 LHCHQRNVSKTWFV-UHFFFAOYSA-N 0.000 description 1
- JVSQVHSJEFXFRT-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-iodobenzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C(=CC=CC=2)I)CC1 JVSQVHSJEFXFRT-UHFFFAOYSA-N 0.000 description 1
- OABROTVIJSOZCG-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methoxyacetamide Chemical compound C1CN(CCNC(=O)COC)CCC1OC1=CC=C(Cl)C(Cl)=C1 OABROTVIJSOZCG-UHFFFAOYSA-N 0.000 description 1
- MQERTRHDLBTFFH-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MQERTRHDLBTFFH-UHFFFAOYSA-N 0.000 description 1
- DYGZKAWWMOSVJK-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methylbenzamide Chemical compound CC1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DYGZKAWWMOSVJK-UHFFFAOYSA-N 0.000 description 1
- VOEFLKXNTZWMOY-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 VOEFLKXNTZWMOY-UHFFFAOYSA-N 0.000 description 1
- JCZWLPKVMPQFQD-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 JCZWLPKVMPQFQD-UHFFFAOYSA-N 0.000 description 1
- CUCPXUJTZQFAEV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenoxyacetamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)COC=2C=CC=CC=2)CC1 CUCPXUJTZQFAEV-UHFFFAOYSA-N 0.000 description 1
- FBTMKTZWRAXPLD-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenylacetamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CC=2C=CC=CC=2)CC1 FBTMKTZWRAXPLD-UHFFFAOYSA-N 0.000 description 1
- MRTWXQBKCWYQLW-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-phenylacetamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CC=2C=CC=CC=2)CC1 MRTWXQBKCWYQLW-UHFFFAOYSA-N 0.000 description 1
- WUBLBLSCBTYXAY-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=C(SC=2)C=2C=CN=CC=2)CC1 WUBLBLSCBTYXAY-UHFFFAOYSA-N 0.000 description 1
- HCZDPNORRYKRTB-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3,5-difluorobenzamide Chemical compound FC1=CC(F)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 HCZDPNORRYKRTB-UHFFFAOYSA-N 0.000 description 1
- ZZJXRWKPAZSRJC-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3,5-dinitrobenzamide Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 ZZJXRWKPAZSRJC-UHFFFAOYSA-N 0.000 description 1
- BIWQWPKNOLOQCG-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-ethoxybenzamide;hydrochloride Chemical compound Cl.CCOC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 BIWQWPKNOLOQCG-UHFFFAOYSA-N 0.000 description 1
- SBCGODLUNFOCIX-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluoro-4-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 SBCGODLUNFOCIX-UHFFFAOYSA-N 0.000 description 1
- KBKXFOOUOMDXLU-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluorobenzamide Chemical compound FC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 KBKXFOOUOMDXLU-UHFFFAOYSA-N 0.000 description 1
- CBWVUHWMSNTREN-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-fluorobenzamide;hydrochloride Chemical compound Cl.FC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 CBWVUHWMSNTREN-UHFFFAOYSA-N 0.000 description 1
- SETIHLUZSWNKTG-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-hydroxybenzamide;hydrochloride Chemical compound Cl.OC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 SETIHLUZSWNKTG-UHFFFAOYSA-N 0.000 description 1
- LBJLDURINCUAHI-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxy-4-methylbenzamide Chemical compound C1=C(C)C(OC)=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 LBJLDURINCUAHI-UHFFFAOYSA-N 0.000 description 1
- WOCAUAGFAOCBHT-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 WOCAUAGFAOCBHT-UHFFFAOYSA-N 0.000 description 1
- HTVQOZOZAIYPRA-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methoxybenzamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 HTVQOZOZAIYPRA-UHFFFAOYSA-N 0.000 description 1
- YSRLFWOFKGYOFR-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 YSRLFWOFKGYOFR-UHFFFAOYSA-N 0.000 description 1
- YTUKBSHEPUURCK-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-methylfuran-2-carboxamide Chemical compound C1=COC(C(=O)NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1C YTUKBSHEPUURCK-UHFFFAOYSA-N 0.000 description 1
- DZAFQLBGKORWFO-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-3-phenylpropanamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CCC=2C=CC=CC=2)CC1 DZAFQLBGKORWFO-UHFFFAOYSA-N 0.000 description 1
- MZVLWYDCCWHQFH-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4,5-dimethylfuran-2-carboxamide Chemical compound O1C(C)=C(C)C=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 MZVLWYDCCWHQFH-UHFFFAOYSA-N 0.000 description 1
- QOYIEWYJWVPSNB-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4,6-dimethoxypyrimidin-2-amine Chemical compound COC1=CC(OC)=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 QOYIEWYJWVPSNB-UHFFFAOYSA-N 0.000 description 1
- OJMHDQHNQCORBV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-(furan-3-yl)pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C2=COC=C2)CC1 OJMHDQHNQCORBV-UHFFFAOYSA-N 0.000 description 1
- FVYCULJCSOBDLR-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-(trifluoromethyl)pyrimidin-2-amine Chemical compound FC(F)(F)C1=CC=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 FVYCULJCSOBDLR-UHFFFAOYSA-N 0.000 description 1
- ZYHXWIHFKNVOSJ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-ethoxybenzamide Chemical compound C1=CC(OCC)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 ZYHXWIHFKNVOSJ-UHFFFAOYSA-N 0.000 description 1
- MMRUIYLXLJUSGC-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-iodobenzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=CC(I)=CC=2)CC1 MMRUIYLXLJUSGC-UHFFFAOYSA-N 0.000 description 1
- LSECCOKTVBGCPQ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methyl-3-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 LSECCOKTVBGCPQ-UHFFFAOYSA-N 0.000 description 1
- VZWJVDVJJFOVHX-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-methylbenzamide Chemical compound C1=CC(C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 VZWJVDVJJFOVHX-UHFFFAOYSA-N 0.000 description 1
- NMOPBBNBMLLCEV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-nitrobenzamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 NMOPBBNBMLLCEV-UHFFFAOYSA-N 0.000 description 1
- REXMJLJELCTNFZ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-phenylbutanamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)CCCC=2C=CC=CC=2)CC1 REXMJLJELCTNFZ-UHFFFAOYSA-N 0.000 description 1
- VEEOQIODRFAASP-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-phenylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C=2C=CC=CC=2)CC1 VEEOQIODRFAASP-UHFFFAOYSA-N 0.000 description 1
- RZTSRZKJOOOKMA-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-propan-2-yloxybenzamide Chemical compound C1=CC(OC(C)C)=CC=C1C(=O)NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 RZTSRZKJOOOKMA-UHFFFAOYSA-N 0.000 description 1
- ISOOYEFAGWGFOV-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-propylsulfanylpyrimidin-2-amine Chemical compound CCCSC1=CC=NC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 ISOOYEFAGWGFOV-UHFFFAOYSA-N 0.000 description 1
- ZGHGGEVGIQQCMZ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-4-pyridin-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=C(C=CN=2)C=2C=NC=CC=2)CC1 ZGHGGEVGIQQCMZ-UHFFFAOYSA-N 0.000 description 1
- VNGXYAQDIVSFEJ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-1-benzofuran-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 VNGXYAQDIVSFEJ-UHFFFAOYSA-N 0.000 description 1
- XHZUGNRUYREDGZ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-2-methylpyrimidin-4-amine Chemical compound COC1=CN=C(C)N=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 XHZUGNRUYREDGZ-UHFFFAOYSA-N 0.000 description 1
- DJOYNOJKWBOLTJ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methoxy-2-methylsulfanylpyrimidin-4-amine Chemical compound COC1=CN=C(SC)N=C1NCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 DJOYNOJKWBOLTJ-UHFFFAOYSA-N 0.000 description 1
- AHSSAFRUOLFUBM-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC=NC=1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 AHSSAFRUOLFUBM-UHFFFAOYSA-N 0.000 description 1
- BNSSXUYAHFYQHZ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-6-methyl-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC(C)=CC(NCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 BNSSXUYAHFYQHZ-UHFFFAOYSA-N 0.000 description 1
- LIMGNCBIBIFOEN-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-ethoxy-1-benzofuran-2-carboxamide Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 LIMGNCBIBIFOEN-UHFFFAOYSA-N 0.000 description 1
- CNUGRMNAHHHHRM-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-methoxy-1-benzofuran-2-carboxamide Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(=O)NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 CNUGRMNAHHHHRM-UHFFFAOYSA-N 0.000 description 1
- OJZLSZAYGQCTEK-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7-methylthieno[3,2-d]pyrimidin-4-amine Chemical compound N1=CN=C2C(C)=CSC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 OJZLSZAYGQCTEK-UHFFFAOYSA-N 0.000 description 1
- YRFKXMUBFJVPGU-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-7H-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC2=C3N=CN=C3N=CN2)CC1 YRFKXMUBFJVPGU-UHFFFAOYSA-N 0.000 description 1
- OTUMJJOKQMKNJO-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]-9-methylpurin-6-amine Chemical compound N1=CN=C2N(C)C=NC2=C1NCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 OTUMJJOKQMKNJO-UHFFFAOYSA-N 0.000 description 1
- DWHOBDRNYCOIBB-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]benzamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=CC=CC=2)CC1 DWHOBDRNYCOIBB-UHFFFAOYSA-N 0.000 description 1
- OHVFGEMUTFGUOR-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]bicyclo[2.2.1]hept-2-ene-5-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2C3CC(C=C3)C2)CC1 OHVFGEMUTFGUOR-UHFFFAOYSA-N 0.000 description 1
- KWRJZKYBEXODFN-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]cyclobutanecarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2CCC2)CC1 KWRJZKYBEXODFN-UHFFFAOYSA-N 0.000 description 1
- BLPURSJNUZZDBX-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]cyclohexanecarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2CCCCC2)CC1 BLPURSJNUZZDBX-UHFFFAOYSA-N 0.000 description 1
- PZAASYQJPDVLGT-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]cyclopentanecarboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C2CCCC2)CC1 PZAASYQJPDVLGT-UHFFFAOYSA-N 0.000 description 1
- ZOFJDGSINAIGAX-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC=CC=2)CC1 ZOFJDGSINAIGAX-UHFFFAOYSA-N 0.000 description 1
- LPMFADILUGHIAD-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]furan-2-carboxamide;hydrochloride Chemical compound Cl.C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2OC=CC=2)CC1 LPMFADILUGHIAD-UHFFFAOYSA-N 0.000 description 1
- YZTPNTWVGMYLQS-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]naphthalene-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2C=C3C=CC=CC3=CC=2)CC1 YZTPNTWVGMYLQS-UHFFFAOYSA-N 0.000 description 1
- ANTCGVOAMRTSJJ-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC=2N=CC=CN=2)CC1 ANTCGVOAMRTSJJ-UHFFFAOYSA-N 0.000 description 1
- ONYTZTZSTPRUHS-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]quinoxaline-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2N=C3C=CC=CC3=NC=2)CC1 ONYTZTZSTPRUHS-UHFFFAOYSA-N 0.000 description 1
- FSZPXCGKPJLDGK-UHFFFAOYSA-N N-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethyl]thiophene-2-carboxamide Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCNC(=O)C=2SC=CC=2)CC1 FSZPXCGKPJLDGK-UHFFFAOYSA-N 0.000 description 1
- GCVCTXVBOIRBAE-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-2-(2,3-dihydro-1,4-benzodioxin-3-yl)-1,3-thiazole-4-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2N=C(SC=2)C2OC3=CC=CC=C3OC2)CC1 GCVCTXVBOIRBAE-UHFFFAOYSA-N 0.000 description 1
- KQDWDIXMRXFLKT-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-2-phenoxyacetamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)COC=2C=CC=CC=2)CC1 KQDWDIXMRXFLKT-UHFFFAOYSA-N 0.000 description 1
- ZZOZJHGDXJFENS-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-[2-(methylamino)-2-oxoethoxy]benzamide;hydrochloride Chemical compound Cl.CNC(=O)COC1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 ZZOZJHGDXJFENS-UHFFFAOYSA-N 0.000 description 1
- UGTFRXYQCXLGLY-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-cyanobenzamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=C(C=CC=2)C#N)CC1 UGTFRXYQCXLGLY-UHFFFAOYSA-N 0.000 description 1
- DPCKMLABADQZQK-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-methylbenzamide Chemical compound CC1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 DPCKMLABADQZQK-UHFFFAOYSA-N 0.000 description 1
- BCXZRGJIBCYTLQ-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-3-nitrobenzamide Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)NCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1 BCXZRGJIBCYTLQ-UHFFFAOYSA-N 0.000 description 1
- SRSUXJTVUYNDTA-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-methyl-3-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(C)=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SRSUXJTVUYNDTA-UHFFFAOYSA-N 0.000 description 1
- VVAOLFLNBAIMMQ-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-methylbenzamide Chemical compound C1=CC(C)=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 VVAOLFLNBAIMMQ-UHFFFAOYSA-N 0.000 description 1
- SGGCUGPPYADYEG-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]-4-nitrobenzamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)NCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 SGGCUGPPYADYEG-UHFFFAOYSA-N 0.000 description 1
- UIHNEYBTKXCMPS-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]benzamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=CC=CC=2)CC1 UIHNEYBTKXCMPS-UHFFFAOYSA-N 0.000 description 1
- NNTVHXHZODJAQQ-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]bicyclo[2.2.1]hept-2-ene-5-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C2C3CC(C=C3)C2)CC1 NNTVHXHZODJAQQ-UHFFFAOYSA-N 0.000 description 1
- AZAIECPMCVIVON-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]cyclohexanecarboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C2CCCCC2)CC1 AZAIECPMCVIVON-UHFFFAOYSA-N 0.000 description 1
- XOWPNWWZNRGDRP-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]furan-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2OC=CC=2)CC1 XOWPNWWZNRGDRP-UHFFFAOYSA-N 0.000 description 1
- GWUDMKBOTHPMTO-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]naphthalene-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2C=C3C=CC=CC3=CC=2)CC1 GWUDMKBOTHPMTO-UHFFFAOYSA-N 0.000 description 1
- UJKHZNIBYNNKDX-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]quinoxaline-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2N=C3C=CC=CC3=NC=2)CC1 UJKHZNIBYNNKDX-UHFFFAOYSA-N 0.000 description 1
- HNMNYNMOFINIKE-UHFFFAOYSA-N N-[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethyl]thiophene-2-carboxamide Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNC(=O)C=2SC=CC=2)CC1 HNMNYNMOFINIKE-UHFFFAOYSA-N 0.000 description 1
- PNAHIPAYIBRUFT-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2SC3=CC=CC=C3N=2)CC1 PNAHIPAYIBRUFT-UHFFFAOYSA-N 0.000 description 1
- GTMVVEHZVVCYQH-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,3-benzoxazol-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2OC3=CC=CC=C3N=2)CC1 GTMVVEHZVVCYQH-UHFFFAOYSA-N 0.000 description 1
- JORCUBGWXPAPNG-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1,8-naphthyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C3N=CC=CC3=CC=2)CC1 JORCUBGWXPAPNG-UHFFFAOYSA-N 0.000 description 1
- QGUVTCMYSOSXFE-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-1-methylpyrazolo[3,4-d]pyrimidin-4-amine Chemical compound N1=CN=C2N(C)N=CC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 QGUVTCMYSOSXFE-UHFFFAOYSA-N 0.000 description 1
- NOWGGYMOFSIVHA-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2,6-dimethoxypyrimidin-4-amine Chemical compound COC1=NC(OC)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 NOWGGYMOFSIVHA-UHFFFAOYSA-N 0.000 description 1
- YLZWVBYTKXBFFI-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-(methylsulfanylmethyl)pyrimidin-4-amine Chemical compound CSCC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 YLZWVBYTKXBFFI-UHFFFAOYSA-N 0.000 description 1
- CPXQTHVKAINDHE-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-ethylsulfanyl-6-methylpyrimidin-4-amine Chemical compound CCSC1=NC(C)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 CPXQTHVKAINDHE-UHFFFAOYSA-N 0.000 description 1
- YWBQKEHSNGDHKJ-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-methylsulfanyl-6-(trifluoromethyl)pyrimidin-4-amine Chemical compound FC(F)(F)C1=NC(SC)=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=C1 YWBQKEHSNGDHKJ-UHFFFAOYSA-N 0.000 description 1
- KKEHZASRXRMVEW-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 KKEHZASRXRMVEW-UHFFFAOYSA-N 0.000 description 1
- YSHXZDCGHBLWIB-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4,6-dimethoxypyrimidin-2-amine Chemical compound COC1=CC(OC)=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 YSHXZDCGHBLWIB-UHFFFAOYSA-N 0.000 description 1
- WVOAEJYFEHFEIU-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-(furan-3-yl)pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C2=COC=C2)CC1 WVOAEJYFEHFEIU-UHFFFAOYSA-N 0.000 description 1
- IUKWUWOTBICNEV-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-(trifluoromethyl)pyrimidin-2-amine Chemical compound FC(F)(F)C1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 IUKWUWOTBICNEV-UHFFFAOYSA-N 0.000 description 1
- WPYKSZLRMQEQSG-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-phenylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2C=CC=CC=2)CC1 WPYKSZLRMQEQSG-UHFFFAOYSA-N 0.000 description 1
- WWOINECOLZVMKL-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-propylsulfanylpyrimidin-2-amine Chemical compound CCCSC1=CC=NC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 WWOINECOLZVMKL-UHFFFAOYSA-N 0.000 description 1
- NQSGHKUNRWAANG-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-pyridin-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2C=NC=CC=2)CC1 NQSGHKUNRWAANG-UHFFFAOYSA-N 0.000 description 1
- LULOKMHNHCLNTA-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-thiophen-2-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C=2SC=CC=2)CC1 LULOKMHNHCLNTA-UHFFFAOYSA-N 0.000 description 1
- YRGRRKBIZLQZEY-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-4-thiophen-3-ylpyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=C(C=CN=2)C2=CSC=C2)CC1 YRGRRKBIZLQZEY-UHFFFAOYSA-N 0.000 description 1
- OGGFUYHLQSDNBL-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methoxy-2-methylpyrimidin-4-amine Chemical compound COC1=CN=C(C)N=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 OGGFUYHLQSDNBL-UHFFFAOYSA-N 0.000 description 1
- KYRIOZQSGUKCBI-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methoxy-2-methylsulfanylpyrimidin-4-amine Chemical compound COC1=CN=C(SC)N=C1NCCCN1CCC(OC=2C=C(Cl)C(Cl)=CC=2)CC1 KYRIOZQSGUKCBI-UHFFFAOYSA-N 0.000 description 1
- QKBVECZBMTUOCW-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-5-methylthieno[2,3-d]pyrimidin-4-amine Chemical compound C=12C(C)=CSC2=NC=NC=1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 QKBVECZBMTUOCW-UHFFFAOYSA-N 0.000 description 1
- CENUZHTZTUCONP-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-6-methyl-2-methylsulfanylpyrimidin-4-amine Chemical compound CSC1=NC(C)=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 CENUZHTZTUCONP-UHFFFAOYSA-N 0.000 description 1
- NTTHUHDBOMNZQH-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-6-methylpyridin-2-amine Chemical compound CC1=CC=CC(NCCCN2CCC(CC2)OC=2C=C(Cl)C(Cl)=CC=2)=N1 NTTHUHDBOMNZQH-UHFFFAOYSA-N 0.000 description 1
- MPDOZIITBQYNNJ-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-7-methylthieno[3,2-d]pyrimidin-4-amine Chemical compound N1=CN=C2C(C)=CSC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 MPDOZIITBQYNNJ-UHFFFAOYSA-N 0.000 description 1
- YBPQRVURRORWIE-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-7H-purin-6-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC2=C3N=CN=C3N=CN2)CC1 YBPQRVURRORWIE-UHFFFAOYSA-N 0.000 description 1
- NCDKWNZTPAKVCQ-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]-9-methylpurin-6-amine Chemical compound N1=CN=C2N(C)C=NC2=C1NCCCN(CC1)CCC1OC1=CC=C(Cl)C(Cl)=C1 NCDKWNZTPAKVCQ-UHFFFAOYSA-N 0.000 description 1
- VODYKEUGXCHTEC-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyridin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=CC=CC=2)CC1 VODYKEUGXCHTEC-UHFFFAOYSA-N 0.000 description 1
- AXGODTPMEJUMJX-UHFFFAOYSA-N N-[3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]propyl]pyrimidin-2-amine Chemical compound C1=C(Cl)C(Cl)=CC=C1OC1CCN(CCCNC=2N=CC=CN=2)CC1 AXGODTPMEJUMJX-UHFFFAOYSA-N 0.000 description 1
- RUHMSOCBISJCEB-UHFFFAOYSA-N N-[4-[[2-[4-(4-chlorobenzoyl)piperidin-1-yl]ethylamino]methyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 RUHMSOCBISJCEB-UHFFFAOYSA-N 0.000 description 1
- 108091006378 SLC25A24 Proteins 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- YLGDPKLRWDOCHX-UHFFFAOYSA-N [1-[2-[(2-chloro-6-fluorophenyl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound FC1=CC=CC(Cl)=C1CNCCN1CCC(C(=O)C=2C=CC(Cl)=CC=2)CC1 YLGDPKLRWDOCHX-UHFFFAOYSA-N 0.000 description 1
- XRJGJSBHSFQMHU-UHFFFAOYSA-N [1-[2-[(4-bromo-1H-pyrazol-5-yl)methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(CCNCC=2C(=CNN=2)Br)CC1 XRJGJSBHSFQMHU-UHFFFAOYSA-N 0.000 description 1
- XCKQLBGYDBLQCS-UHFFFAOYSA-N [1-[2-[[5-chloro-1-methyl-3-(trifluoromethyl)pyrazol-4-yl]methylamino]ethyl]piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound CN1N=C(C(F)(F)F)C(CNCCN2CCC(CC2)C(=O)C=2C=CC(Cl)=CC=2)=C1Cl XCKQLBGYDBLQCS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 102000009410 chemokine receptors Human genes 0.000 description 1
- 108050000299 chemokine receptors Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004820 halides Chemical group 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- NSKZINWLPRKWDC-UHFFFAOYSA-N methyl 4-[2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]ethylamino]-4-oxobutanoate Chemical compound C1CN(CCNC(=O)CCC(=O)OC)CCC1OC1=CC=C(Cl)C(Cl)=C1 NSKZINWLPRKWDC-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000051 modifying Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901117A SE9901117D0 (sv) | 1999-03-26 | 1999-03-26 | Novel compounds |
| SE9901117-3 | 1999-06-10 | ||
| SE9902194-1 | 1999-06-10 | ||
| SE9902194A SE9902194D0 (sv) | 1999-06-10 | 1999-06-10 | Novel compounds |
| PCT/SE2000/000563 WO2000058305A1 (en) | 1999-03-26 | 2000-03-22 | Novel compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002540204A JP2002540204A (ja) | 2002-11-26 |
| JP2002540204A5 true JP2002540204A5 (US20050059668A1-20050317-C00061.png) | 2007-04-26 |
Family
ID=26663543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000608007A Pending JP2002540204A (ja) | 1999-03-26 | 2000-03-22 | 新規化合物 |
Country Status (18)
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2361366A1 (en) | 1999-03-26 | 2000-10-05 | Nicholas Kindon | Novel compounds |
| SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| DE19952147A1 (de) * | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| GB0004153D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| GB0004151D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
| GB0004152D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
| CO5300399A1 (es) * | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen |
| GB0013060D0 (en) * | 2000-05-31 | 2000-07-19 | Astrazeneca Ab | Chemical compounds |
| US7005439B2 (en) | 2000-06-20 | 2006-02-28 | Astrazeneca Ab | Compounds |
| AR028948A1 (es) | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
| TWI227231B (en) | 2000-07-12 | 2005-02-01 | Novartis Ag | 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3 |
| GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| WO2002030899A1 (en) * | 2000-10-09 | 2002-04-18 | Novartis Ag | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| AU2001295601A1 (en) | 2000-10-09 | 2002-04-22 | Novartis Pharma Gmbh | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| UY27003A1 (es) | 2000-11-06 | 2002-07-31 | Schering Ag | Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer |
| GB0104050D0 (en) | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| AR035230A1 (es) | 2001-03-19 | 2004-05-05 | Astrazeneca Ab | Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos |
| GB0107228D0 (en) | 2001-03-22 | 2001-05-16 | Astrazeneca Ab | Chemical compounds |
| SE0101038D0 (sv) | 2001-03-23 | 2001-03-23 | Astrazeneca Ab | Novel compounds |
| KR20040015191A (ko) | 2001-04-27 | 2004-02-18 | 미쯔비시 웰 파마 가부시키가이샤 | 신규 벤질피페리딘 화합물 |
| GB0114699D0 (en) * | 2001-06-15 | 2001-08-08 | Novartis Ag | Organic compounds |
| GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
| GB0117899D0 (en) | 2001-07-23 | 2001-09-12 | Astrazeneca Ab | Chemical compounds |
| SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
| SE0102809D0 (sv) * | 2001-08-22 | 2001-08-22 | Astrazeneca Ab | Novel compounds |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| TW200303304A (en) * | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
| KR101297924B1 (ko) * | 2002-07-29 | 2013-08-20 | 리겔 파마슈티칼스, 인크. | 2,4-피리미딘디아민 화합물을 이용한 자가면역질환의 치료및 예방 방법 |
| DE60330466D1 (de) * | 2002-07-29 | 2010-01-21 | Rigel Pharmaceuticals Inc | VERFAHREN ZUR BEHANDLUNG ODER PRuVENTION VON AUTOIMMUNKRANKHEITEN MIT 2,4-PYRIMIDINDIAMIN-VERBINDUNGEN |
| SI1534286T1 (sl) * | 2002-07-29 | 2010-04-30 | Rigel Pharmaceuticals Inc | Postopki za zdravljenje ali prepreŽŤevanje avtoimunskih bolezni z 2,4-pirimidindiaminskimi spojinami |
| WO2004048343A1 (en) * | 2002-11-28 | 2004-06-10 | Schering Aktiengesellschaft | Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| WO2004054974A2 (en) * | 2002-12-13 | 2004-07-01 | Smithkline Beecham Corporation | Piperidine derivatives as ccr5 antagonists |
| TWI344955B (en) | 2003-03-14 | 2011-07-11 | Ono Pharmaceutical Co | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient |
| US7498323B2 (en) | 2003-04-18 | 2009-03-03 | Ono Pharmaceuticals Co., Ltd. | Spiro-piperidine compounds and medicinal use thereof |
| NZ545270A (en) | 2003-07-30 | 2010-04-30 | Rigel Pharmaceuticals Inc | 2,4-Pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| WO2005040129A2 (en) * | 2003-10-24 | 2005-05-06 | F. Hoffmann-La Roche Ag | Ccr3 receptor antagonists |
| SE0400208D0 (sv) * | 2004-02-02 | 2004-02-02 | Astrazeneca Ab | Chemical compounds |
| GB0412468D0 (en) * | 2004-06-04 | 2004-07-07 | Astrazeneca Ab | Chemical compounds |
| EP1758580A4 (en) | 2004-06-24 | 2008-01-16 | Incyte Corp | N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT |
| PT1801108E (pt) | 2004-09-08 | 2012-12-03 | Mitsubishi Tanabe Pharma Corp | Composto de morfolina para o tratamento de inflamações |
| TWI400232B (zh) | 2004-09-13 | 2013-07-01 | Ono Pharmaceutical Co | 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑 |
| ES2380550T3 (es) | 2004-11-24 | 2012-05-16 | Rigel Pharmaceuticals, Inc. | Compuestos de espiro-2,4-pirimidindiamina y sus usos |
| US7576080B2 (en) * | 2004-12-23 | 2009-08-18 | Memory Pharmaceuticals Corporation | Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| JPWO2006129679A1 (ja) | 2005-05-31 | 2009-01-08 | 小野薬品工業株式会社 | スピロピペリジン化合物およびその医薬用途 |
| WO2006138350A2 (en) * | 2005-06-15 | 2006-12-28 | Anormed Inc. | Chemokine receptor binding compounds |
| TW200738634A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
| US8318931B2 (en) | 2005-10-28 | 2012-11-27 | Ono Pharmaceutical Co., Ltd. | Chemokine receptor antagonists and use thereof |
| TW200800895A (en) * | 2005-11-02 | 2008-01-01 | Astrazeneca Ab | Novel compounds |
| JP5217438B2 (ja) | 2005-11-18 | 2013-06-19 | 小野薬品工業株式会社 | 塩基性基を含有する化合物およびその用途 |
| BRPI0707960A2 (pt) * | 2006-02-17 | 2011-05-10 | Hoffmann La Roche | derivados de benzoil-piperidina como moduladores de 5ht2/d3, medicamento e uso dos mesmos |
| EP1994003A4 (en) * | 2006-03-07 | 2009-12-02 | Astrazeneca Ab | PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY |
| EP1994002A1 (en) * | 2006-03-07 | 2008-11-26 | AstraZeneca AB | Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| AU2007225836A1 (en) | 2006-03-10 | 2007-09-20 | Ono Pharmaceutical Co., Ltd. | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| JP5257068B2 (ja) | 2006-05-16 | 2013-08-07 | 小野薬品工業株式会社 | 保護されていてもよい酸性基を含有する化合物およびその用途 |
| EP2054392A2 (en) * | 2006-06-15 | 2009-05-06 | Boehringer Ingelheim International GmbH | 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| MX2008016007A (es) | 2006-06-15 | 2009-01-16 | Boehringer Ingelheim Int | 2-anilino-4-aminoalquilenoaminopirimidinas. |
| EP2055705A4 (en) | 2006-07-31 | 2014-08-20 | Ono Pharmaceutical Co | COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF |
| ES2401663T3 (es) | 2006-10-31 | 2013-04-23 | F. Hoffmann-La Roche Ag | Derivados éter moduladores duales de los receptores de 5-HT2a y D3 |
| WO2008097976A1 (en) * | 2007-02-09 | 2008-08-14 | Kalypsys, Inc. | Heterocyclic modulators of tgr5 for treatment of disease |
| EP2132186A1 (en) * | 2007-03-06 | 2009-12-16 | Novartis AG | Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| CA2692050A1 (en) * | 2007-06-12 | 2008-12-18 | F.Hoffmann-La Roche Ag | Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| JP5736171B2 (ja) * | 2007-09-24 | 2015-06-17 | ジェネンテック， インコーポレイテッド | チアゾロピリミジンｐｉ３ｋ阻害剤化合物および使用方法 |
| EP3106166B1 (en) * | 2008-02-29 | 2020-12-02 | VM Therapeutics LLC | Compounds for treating pain syndrome and other disorders |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| US9938281B2 (en) | 2012-11-16 | 2018-04-10 | Merck Sharp & Dohme Corp. | Purine inhibitors of human phosphatidylinositol 3-kinase delta |
| CN111004218B (zh) * | 2018-10-08 | 2023-10-13 | 沈阳中化农药化工研发有限公司 | 含哌啶的嘧啶类化合物及用途 |
| US10702525B1 (en) * | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
| WO2021217143A1 (en) * | 2020-04-24 | 2021-10-28 | Emory University | Aminopiperidine amides, derivatives, compositions, and uses related to cxcr4 modulation |
| WO2021241876A1 (ko) * | 2020-05-29 | 2021-12-02 | 재단법인 대구경북첨단의료산업진흥재단 | 카복사미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335127A (en) | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| DK159420C (da) * | 1983-03-09 | 1991-03-11 | Ciba Geigy Ag | N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater |
| FI853477L (fi) * | 1984-09-14 | 1986-03-15 | Ciba Geigy Ag | Foerfarande foer framstaellning av karbonylfoereningar. |
| CA1246074A (en) | 1984-12-05 | 1988-12-06 | Albertus H.M.T. Van Heertum | Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines |
| KR910006138B1 (ko) | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| JP2860689B2 (ja) * | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | ピリミジン誘導体 |
| FR2667317B1 (fr) * | 1990-10-02 | 1992-12-04 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
| US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| FR2724382B1 (fr) * | 1994-09-13 | 1996-10-18 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique |
| CN1184478A (zh) * | 1995-03-22 | 1998-06-10 | 大正制药株式会社 | 噻唑衍生物 |
| JPH0940646A (ja) * | 1995-07-27 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | ベンゼン縮合環誘導体又はその塩 |
| JPH0977742A (ja) * | 1995-09-12 | 1997-03-25 | Kyorin Pharmaceut Co Ltd | 新規なベンズアミド誘導体 |
| AU727972B2 (en) | 1996-05-16 | 2001-01-04 | H. Lundbeck A/S | Dihydropyrimidines and uses thereof |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| EP1047675A1 (en) * | 1998-01-21 | 2000-11-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) * | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| CN1163484C (zh) | 1998-11-17 | 2004-08-25 | 霍夫曼-拉罗奇有限公司 | 4-芳酰基-哌啶-ccr-3受体拮抗剂ⅲ |
| CA2361366A1 (en) | 1999-03-26 | 2000-10-05 | Nicholas Kindon | Novel compounds |
-
2000
- 2000-03-22 CA CA002361366A patent/CA2361366A1/en not_active Abandoned
- 2000-03-22 TR TR2001/02800T patent/TR200102800T2/xx unknown
- 2000-03-22 AU AU41575/00A patent/AU4157500A/en not_active Abandoned
- 2000-03-22 CZ CZ20013451A patent/CZ20013451A3/cs unknown
- 2000-03-22 WO PCT/SE2000/000563 patent/WO2000058305A1/en not_active Application Discontinuation
- 2000-03-22 CN CN00805451A patent/CN1344266A/zh active Pending
- 2000-03-22 PL PL00350904A patent/PL350904A1/xx not_active Application Discontinuation
- 2000-03-22 EP EP00921237A patent/EP1165545A1/en not_active Withdrawn
- 2000-03-22 JP JP2000608007A patent/JP2002540204A/ja active Pending
- 2000-03-22 KR KR1020017012174A patent/KR20010108394A/ko not_active Application Discontinuation
- 2000-03-22 US US09/555,565 patent/US6518286B1/en not_active Expired - Fee Related
- 2000-03-22 EE EEP200100502A patent/EE200100502A/xx unknown
- 2000-03-22 HU HU0202017A patent/HUP0202017A3/hu unknown
- 2000-03-22 IL IL14435300A patent/IL144353A0/xx unknown
- 2000-03-22 SK SK1182-2001A patent/SK11822001A3/sk unknown
- 2000-03-22 BR BR0009338-6A patent/BR0009338A/pt not_active IP Right Cessation
-
2001
- 2001-07-26 IS IS6024A patent/IS6024A/is unknown
- 2001-09-17 NO NO20014518A patent/NO20014518L/no unknown
-
2003
- 2003-01-09 US US10/339,261 patent/US6946478B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002540204A5 (US20050059668A1-20050317-C00061.png) | ||
| CN1344266A (zh) | 新的化合物 | |
| RU2011116226A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2007513957A5 (US20050059668A1-20050317-C00061.png) | ||
| KR101078505B1 (ko) | 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제 | |
| RU2006139952A (ru) | Производные 1-аминофталазина, их получение и их применение в терапии | |
| RU2007114125A (ru) | Замещенные гидантоины для лечения рака | |
| JP2007519754A5 (US20050059668A1-20050317-C00061.png) | ||
| JP2005533803A5 (US20050059668A1-20050317-C00061.png) | ||
| JP2003507328A5 (US20050059668A1-20050317-C00061.png) | ||
| JP2005526723A5 (US20050059668A1-20050317-C00061.png) | ||
| JP2007519753A5 (US20050059668A1-20050317-C00061.png) | ||
| SK16152002A3 (sk) | Farmacueticky účinné piperidínové deriváty, najmä ako modulátory aktivity chemokínového receptora | |
| RU2005134006A (ru) | Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера | |
| RU2004127925A (ru) | N3-алкилированные бензимидазольные производные в качестве ингибиторов мек | |
| JP2004509953A5 (US20050059668A1-20050317-C00061.png) | ||
| SK82398A3 (en) | 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists | |
| RU2015150946A (ru) | Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения | |
| RU2007130532A (ru) | Дизамещенные мочевины в качестве ингибиторов киназы | |
| JP2009544620A (ja) | 自己免疫疾患及び炎症のためのプロリン尿素ｃｃｒ１アンタゴニスト | |
| RU2005132616A (ru) | Производные 2-фенокси и 2-фенилсульфонамида с ссr3 антагонистической активностью для лечения астмы и других воспалительных или иммунологических заболеваний | |
| JP2008502614A5 (US20050059668A1-20050317-C00061.png) | ||
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| ES2310032T3 (es) | Derivados de 2-ariletil-(piperidin-4-ilmetil)amina como antagonistas de receptores muscarinicos. | |
| RU2006128445A (ru) | Ацетилиновые пиперазиновые соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов |
